Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 06, 2022 08:30 ET | Source: Runway Growth Finance Corp.

Runway Growth Finance Corp. Provides Third Quarter 2022 Portfolio Update

Completed Nine Investments in New and Existing Portfolio Companies Representing $216 Million in New Commitments and $161 Million in Funded LoansTotal Loan Commitments and Funded Investments Grew to...
October 06, 2022 08:30 ET | Source: Odyssey Health, Inc

Odyssey Health, Inc. Provides Recap on Concussion Drug Development

Las Vegas, Nevada, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
October 06, 2022 08:30 ET | Source: ARHT Media Inc.

ARHT Media beams in Erin Brockovich and Adam Grant during Energy Disruptors: UNITE summit

TORONTO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- ARHT Media Inc. (“ARHT Media” or “ARHT” or the “Company”) [TSXV:ART], the global leader in the development, production and distribution of high-quality and...
October 06, 2022 08:30 ET | Source: Mustang Bio, Inc.

Mustang Bio Announces First Patient Treated in Its Multicenter Phase 1/2 Clinical Trial of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy to Treat B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Enrollment continues in clinical trial of MB-106 under Mustang’s IND; next data disclosure anticipated 4Q 2022 Ongoing clinical trial of MB-106 at Fred Hutch continues to demonstrate high efficacy,...
October 06, 2022 08:30 ET | Source: Grayscale Investments

Grayscale Investments® Announces New Co-Investment Opportunity Designed to Capture Upside of Crypto Winter

STAMFORD, Conn., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Grayscale Investments®, the world’s largest digital currency asset manager, today announced the formation of Grayscale Digital Infrastructure...
October 06, 2022 08:30 ET | Source: Achilles Therapeutics PLC

Achilles Therapeutics Co-founder Professor Charles Swanton to Participate in Expert Roundtable Highlighting Pivotal Nature of Neoantigens as Targets in Cancer Cell Therapy

Professor Swanton joins Achilles SAB member Dr. Christopher Klebanoff and Dr. John Haanen on the key opinion leader panel to discuss neoantigens as valuable immunotherapy targets Virtual Roundtable...
October 06, 2022 08:30 ET | Source: ICU Medical, Inc.

ICU Medical Announces Time of Third Quarter 2022 Earnings Conference Call

SAN CLEMENTE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of...
October 06, 2022 08:30 ET | Source: FullThrottle Technologies, LLC

FullThrottle Announces Launch of Audience Flume to Offer Turnkey Access to Novel First-Party Data

PHILADELPHIA, Oct. 06, 2022 (GLOBE NEWSWIRE) -- FullThrottle Technologies, LLC, an end-to-end privacy-compliant first-party data platform that helps marketers identify and target audiences and...
October 06, 2022 08:30 ET | Source: Bridger Aerospace, LLC

Bridger Aerospace Appoints Eric Gerratt as Chief Financial Officer Ahead of Planned Business Combination

BOZEMAN, Mont., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, LLC (“Bridger” or the “Company”), a leading independent provider of aerial firefighting services, has appointed...
October 06, 2022 08:30 ET | Source: Acer Therapeutics Inc.

Acer Therapeutics Announces University of North Carolina Receives Department of Defense Grant to Support the Proposed Investigator Sponsored OASIS Trial of ACER-801 (Osanetant) to Reduce the Frequency and Severity of Post-Traumatic Stress Disorder

$3 million awarded to University of North Carolina (UNC) to support a proposed 180-patient, randomized, placebo-controlled trial in trauma patients Proposed investigator sponsored trial to...

1 ...78284 78285 78286 ...326068